相关实验视频
Updated: Jun 19, 2026
10:53
Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
5.4K
心肌工作评估,以改善基线风险分层在 transthyretin 氨基粉症的患者
Ana Moya1,2, Elayne Kelen de Oliveira1,3, Monika Beles2
1CardioPath PhD Program, Federico II University Hospital, Naples, Italy.
International journal of cardiology. Heart & vasculature
|February 6, 2025
概括
心肌工作 (MW) 分析,特别是全球建设性工作 (GCW),改善了心脏转氨基粉症 (ATTR) 患者的风险分层. GCW将患者重新分类到NACII阶段,确定一个具有明显更差预后的高风险组.
科学领域:
- 心脏病学 心脏病学
- 心血管成像 - 心血管成像
- 氨基粉症研究研究
背景情况:
- 心脏中转氨基粉症 (ATTR) 往往被低诊断并致死.
- 国家粉症中心 (NAC) 的分期系统使用NT-proBNP和eGFR进行生存预测.
- NACII期患者的预后异质,需要改善风险分层.
研究的目的:
- 评估心肌工作 (MW) 分析在增强ATTR患者风险分层方面的作用.
- 为了确定MW参数是否可以在当前的NAC分期系统之外完善预后预测.
- 确定接受治疗的ATTR患者生存的新型预测因子.
主要方法:
- 对37名ATTR患者的回顾性研究 (2021年3月 - 2023年8月).
- 从心声学收集基线NT-proBNP,eGFR,LVEF,GLS和MW参数.
- 将患者分类为NACI,II和III阶段的患者.
主要成果:
- 与I阶段相比,在NACII和III阶段的生存率明显较差.
- 全球建设性工作 (GCW) 成为最好的生存预测指标 (AUC:0.7),最佳切断值为1294 mmHg%.
- 对使用GCW的NACII期患者进行重新分层,确定了一个高风险组,在2年内生存率为40%.
结论:
- 心肌工作分析,特别是GCW,为ATTR的基线风险分层提供了显著的优势.
- 结合GCW切断值可以完善ATTR患者的预后准确性,特别是在NACII阶段.
- 这种方法有助于识别可能受益于加强管理策略的高风险患者.
相关概念视频
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:30Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...